Gene silencing of NFκB, a downstream target for TLR4, prevents PCH and its progression to heart failure in a transgenic myotrophin model [28] while TLR4-deficient mice are resistant to pressure overload-induced PCH and heart failure [29]. The gene discussed is TLR4; the disease is heart failure.